• Raye Elaine, BCPA

Co-pay Relief Assistance for Covid-19

PAF’s Co-Pay Relief Expanded Assistance Through the

COVID-19 Fund to Better Address Patient Needs

Beginning on March 1, 2021, PAF’s Co-Pay Relief (CPR) program expanded its assistance to cover additional expenses incurred by those diagnosed with COVID-19 and increased the grant award to $3000 for new and renewing patients.

In response to identified support needs that exist for patients diagnosed with COVID-19 and who are eligible for support from the COVID-19 fund, CPR will now cover additional expenses including:

  • Medical insurance premiums

  • Current, new, and renewing patients receiving assistance from the COVID-19 fund can use their award to reimburse for individual health insurance premiums, or to have their insurance premiums paid directly to their insurance provider.

  • Over the counter(OTC) medications

  • Current, new, and renewing patients receiving assistance from the COVID-19 fund can use their grant for OTC medications, using the Virtual Pharmacy Card to pay at the pharmacy for products to manage the symptoms associated with COVID-19 or submit for reimbursement for OTC medications already purchased.

  • Office visit co-payment expenses associated with the diagnosis and/or treatment of COVID-19.

In addition, the COVID-19 grant award has been increased to $3000 for all new or renewal applications received on or after 3/1/2021.

To learn more, or to apply for assistance, please visit or call our dedicated CPR staff toll-free at 866-512-3861.

The Co-Pay Relief Program may help eligible patients with all therapeutic and supportive medications, including generic or bioequivalent products prescribed to treat and/or manage the patient’s disease or condition. The program helps patients on a first-come, first-serve basis and processes applicants in the order in which completed applications are received.

1 view0 comments

Recent Posts

See All

Many people may not be aware that the pharmaceutical companies have been ruthlessly increasing the cost of life sustaining insulin far beyond the actual cost of production. Insulin prices can range fr